EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC 4.0

Adverse metabolic consequences of androgen deprivation therapy (ADT) on Asian patients with prostate cancer: Primary results from the real‐life experience of ADT in Asia (READT) study

Chris H M Wong iD, Ning Xu, Jasmine Lim iD, Kuo-Kang Feng, Wayne K W Chan, Marco T Y Chan, Steven Ch Leung iD, Dong-Ning Chen, Yun-Zhi Lin, Peter K F Chiu, Chi Hang Yee, Jeremy Y C Teoh und 5 weitere

The Prostate · 2023

DOI: 10.1002/pros.24519 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift The Prostate, 2023. Verfasst von Chris H M Wong und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, SH Ho Urology Centre, The Chinese University of Hong Kong, Hong Kong, Hong Kong. Hauptthemen laut MEDLINE: Prostatic Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Androgen deprivation therapy (ADT) use in prostate cancer (PCa) has seen a rising trend. We investigated the relationship between ADT and adverse changes in metabolic parameters in an Asian population.

Methods

This is an international prospective multicenter single‐arm cohort yielded from the real‐life experience of ADT in Asia (READT) registry. Consecutive ADT‐naïve patients diagnosed of PCa and started on ADT were prospectively recruited from 2016 and analyzed. Baseline patient characteristics, PCa disease status, and metabolic parameters were documented. Patients were followed up at 6‐month interval for up to 5 years. Metabolic parameters including body weight, lipid profiles, and glycemic profiles were recorded and analyzed.

Results

589 patients were eligible for analysis. ADT was associated with adverse glycemic profiles, being notable at 6 months upon ADT initiation and persisted beyond 1 year. Comparing to baseline, fasting glucose level and hemoglobin A1c level increased by 4.8% ( p < 0.001) and 2.7% ( p < 0.001), respectively. Triglycerides level was also elevated by 16.1% at 6th month and by 20.6% at 12th month compared to baseline ( p < 0.001). Mean body weight was 1.09 kg above baseline at 18th month ( p < 0.001).

Conclusion

ADT was associated with adverse metabolic parameters in terms of glycemic profiles, lipid profiles, and body weight in the Asian population. These changes developed early in the treatment and can persist beyond the first year. Regular monitoring of the biochemical profiles during treatment is paramount in safeguarding the patients' metabolic health.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsMaleHumansAndrogensAndrogen AntagonistsProspective StudiesAsiaBody WeightLipids

Stichwörter der Autor:innen

Asianandrogen deprivation therapymetabolic outcomes

Substanzen

AndrogensAndrogen AntagonistsLipids

Autor:innen und Institutionen

  • Department of Surgery, SH Ho Urology Centre, The Chinese University of Hong Kong, Hong Kong, Hong Kong.
  • Department of Surgery, Division of Urology, Prince of Wales Hospital, Shatin, Hong Kong.
  • Department of Surgery, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China.
  • Department of Surgery, Urology Unit, University of Malaya, Kuala Lumpur, Malaysia.
  • Department of Urology, Hsin-Chu BioMedical Park Hospital, National Taiwan University Hospital, Taipei, Taiwan.
  • Department of Surgery, Division of Urology, Kwong Wah Hospital, Mongkok, Kowloon, Hong Kong.

ORCID-Profile: Chris H M Wong, Jasmine Lim, Steven Ch Leung, Wei-Sien Yeoh

Zitieren

APA

Wong, C. H. M., Xu, N., Lim, J., Feng, K. K., Chan, W. K. W., Chan, M. T. Y., Leung, S. C., Chen, D. N., Lin, Y. Z., Chiu, P. K. F., Yee, C. H., Teoh, J. Y. C., Huang, C. Y., Yeoh, W. S., Ong, T. A., Wei, Y., & Ng, C. F. (2023). Adverse metabolic consequences of androgen deprivation therapy (ADT) on Asian patients with prostate cancer: Primary results from the real‐life experience of ADT in Asia (READT) study. The Prostate. https://doi.org/10.1002/pros.24519

Vancouver

Wong CHM, Xu N, Lim J, Feng KK, Chan WKW, Chan MTY, et al. Adverse metabolic consequences of androgen deprivation therapy (ADT) on Asian patients with prostate cancer: Primary results from the real‐life experience of ADT in Asia (READT) study. The Prostate. 2023. doi:10.1002/pros.24519

BibTeX
@article{Wong2023,
  author = {Wong, Chris H M and Xu, Ning and Lim, Jasmine and Feng, Kuo-Kang and Chan, Wayne K W and Chan, Marco T Y and Leung, Steven Ch and Chen, Dong-Ning and Lin, Yun-Zhi and Chiu, Peter K F and Yee, Chi Hang and Teoh, Jeremy Y C and Huang, Chiu-Yuen and Yeoh, Wei-Sien and Ong, Teng-Aik and Wei, Yong and Ng, Chi-Fai},
  title = {Adverse metabolic consequences of androgen deprivation therapy (ADT) on Asian patients with prostate cancer: Primary results from the real‐life experience of ADT in Asia (READT) study},
  journal = {The Prostate},
  year = {2023},
  doi = {10.1002/pros.24519}
}
Kostenlos starten →